28th Jul 2021 18:07
Ap24
AMENDMENT
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN ACLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 25 June 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
1,032,578 | 10.6200 GBP | 10.5500 GBP |
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
22,751(New Loan)* 604,155 | N/A 10.6101 GBP | N/A 10.3498 GBP |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long
Decrease Short
Increase Long
Increase Short
Opening a Short Position | 652
200,000 38,831 1,968 3,986 26,548 696 6,139 97,915 3,600 1,226 1,505 13,283 355
335 8,054 220 1,279
1,808 2,449 111,061 59,600 3,528 2,152 494,173 1,101 1,259 17,976 8,046 1,451 300 15,539 492 1,500 1001
178,043 | 10.5719 GBP
10.4895 GBP 10.5242 GBP 10.5398 GBP 10.5550 GBP 10.5585 GBP 10.5597 GBP 10.5600 GBP 10.5629 GBP 10.5782 GBP 10.5803 GBP 10.5830 GBP 10.5877 GBP 10.6000 GBP
10.5460 GBP 10.5741 GBP 10.5745 GBP 10.5785 GBP
10.5502 GBP 10.5506 GBP 10.5553 GBP 10.5600 GBP 10.5605 GBP 10.5674 GBP 10.5679 GBP 10.5701 GBP 10.5703 GBP 10.5743 GBP 10.5754 GBP 10.5764 GBP 10.5801 GBP 10.5842 GBP 10.5894 GBP 10.5900 GBP 10.5738 GBP
10.5653 GBP |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securitiesunder any option referred to on this form or relating to the voting rights or future acquisitionor disposal of any relevant securities to which any derivative referred to on this form is referenced.If none, this should be stated.
Date of disclosure | 28 July 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Related Shares:
UDG.L